has_DoseForm has_Ingredient drug associated with AE Hydrochlorothiazide [Chemical/Ingredient] irbesartan [Chemical/Ingredient] HYDROCHLOROTHIAZIDE/IRBESARTAN [CV400] ANTIHYPERTENSIVE COMBINATIONS Oral Tablet [Dose Form] HYDROCHLOROTHIAZIDE IRBESARTAN HYDROCHLOROTHIAZIDE 12.5MG/IRBESARTAN 150MG TAB [VA Product] VA Product <Product_Component>HYDROCHLOROTHIAZIDE</Product_Component><Strength>12.5</Strength><Unit>MG</Unit><VA.IEN>209</VA.IEN> HCTZ 12.5/IRBESARTAN 150MG TAB HYDROCHLOROTHIAZIDE/IRBESARTAN TAB 厄贝沙坦氢氯噻嗪片（进口） <Product_Component>IRBESARTAN</Product_Component><Strength>150</Strength><Unit>MG</Unit><VA.IEN>3739</VA.IEN> HYDROCHLOROTHIAZIDE 12.5MG/IRBESARTAN 150MG TAB 310792 0 C0977511 <VANDF_Record>50.68^13407^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>13407</VA_IEN><VA_Status>Active/Master</VA_Status> C42848 4013772 N0000161559 Hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet flushing AE fatigue AE tachycardia AE rash AE myalgia AE asthenia AE dizziness AE edema limbs AE syncope AE hypertension AE dry mouth AE blood creatine phosphokinase level increased AE bone pain AE edema AE nausea AE vomiting AE diarrhea AE blood creatinine level increased AE blood potassium decreased blood sodium decreased blood urea level increased AE dysuria AE libido disorder AE sexual dysfunctions AE orthostatic dizziness AE HYDROCHLOROTHIAZIDE 12.5MG/IRBESARTAN 150MG TAB [VA Product] VA Product C0977511 <Product_Component>HYDROCHLOROTHIAZIDE</Product_Component><Strength>12.5</Strength><Unit>MG</Unit><VA.IEN>209</VA.IEN> <VANDF_Record>50.68^13407^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>13407</VA_IEN><VA_Status>Active/Master</VA_Status> 厄贝沙坦氢氯噻嗪片（进口） <Product_Component>IRBESARTAN</Product_Component><Strength>150</Strength><Unit>MG</Unit><VA.IEN>3739</VA.IEN> HYDROCHLOROTHIAZIDE 12.5MG/IRBESARTAN 150MG TAB 310792 C42848 4013772 0 HCTZ 12.5/IRBESARTAN 150MG TAB N0000161559 Hydrochlorothiazide 12.5 MG / irbesartan 150 MG Oral Tablet HYDROCHLOROTHIAZIDE/IRBESARTAN TAB